Return to the Full Article View You can republish this story for free. Click the "Copy HTML" button below. Questions? Get more details.

Listen: A Podcast Explores Controversial Efforts to Waive Drugmakers’ Vaccine Patent Rights

President Joe Biden has thrown his support to an international effort to waive drugmakers’ patent rights on the covid vaccines, but the pharmaceutical industry vows to fight back. Julie Rovner, KHN’s chief Washington correspondent, joins The Atlantic’s “Social Distance” podcast, hosted by Dr. James Hamblin and Maeve Higgins, to talk about the current patent controversy and how the drug industry has protected itself over the years with vibrant campaigns about the needs for high profits to support drug development.

This story was produced by KHN (Kaiser Health News), a national newsroom that produces in-depth journalism about health issues. Together with Policy Analysis and Polling, KHN is one of the three major operating programs at KFF (Kaiser Family Foundation). KFF is an endowed nonprofit organization providing information on health issues to the nation.

Some elements may be removed from this article due to republishing restrictions. If you have questions about available photos or other content, please contact khnweb@kff.org.